Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Avotaciclib hydrochloride, a CDK1 inhibitor, is the hydrochloride salt of Avotaciclib and exhibits potential therapeutic use in specific malignancies, including pancreatic cancer, characterized by abnormal and pronounced CDK1 expression [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Avotaciclib hydrochloride, a CDK1 inhibitor, is the hydrochloride salt of Avotaciclib and exhibits potential therapeutic use in specific malignancies, including pancreatic cancer, characterized by abnormal and pronounced CDK1 expression [1]. |
Synonyms | BEY1107 hydrochloride |
Molecular Weight | 317.73 |
Formula | C13H12ClN7O |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Avotaciclib hydrochloride Cell Cycle/Checkpoint CDK BEY 1107 Hydrochloride BEY-1107 Hydrochloride BEY1107 Hydrochloride BEY1107 hydrochloride Avotaciclib Hydrochloride inhibitor inhibit